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Specific objective: Guided tissue regeneration (GTR) aims to regenerate the lost 
attachment apparatus caused by periodontal disease through the use of a barrier 
  
 
 
membrane. For the GTR procedures to be successful, barrier membranes are required to 
be present at the surgical site for an extended period of time (weeks to months). Synthetic 
membranes have the advantage of prolonged presence in a wound site; however, they do 
not actively contribute to wound healing. Biologic membranes are recognized by the host 
tissue and participate in wound healing but have the disadvantage of early resorption. 
Therefore, the goal of this study is to create and characterize a hybrid barrier membrane 
that contains biologically active fibrin matrix within a synthetic polymeric electrospun 
scaffold. 
Method: Fibrin matrices and fibrin-incorporated electrospun scaffold were created from 
fresh frozen plasma at three different centrifugation conditions 400g for 12 minutes, 
1450g for 15 minutes and 3000g for 60 minutes.  Following centrifugation, half of the 
membranes were crosslinked with 1% genipin. Biological stability of these scaffolds was 
evaluated by resistance to trypsin while their mechanical properties were characterized by 
MTS Bionix Uniaxial Tensile Testing System. Continuous data was analyzed by 
ANOVA to detect differences between groups (p=0.05). 
Results: The addition of an electrospun scaffold to the fibrin matrix led to improvements 
in the mechanical properties as evidenced by an increase in the modulus (p<0.0001), 
strain at break (p<0.0001) and energy to break (p<0.0001). The effect of crosslinking was 
marginal but not statistically significant to the mechanical properties of fibrin matrices or 
the fibrin incorporated scaffold.  However, crosslinking did significantly increase 
resistance against enzymatic degradation by trypsin (p<0.0001). Lastly, centrifugation 
speeds at 400g and 1450g showed similar mechanical properties and biologic stability; 
meanwhile 3000g negatively impacted the properties of the scaffold.   
  
 
 
Conclusion: Fibrin-incorporated electronspun scaffold exhibits enhanced mechanical and 
biologic stability compared to fibrin matrices alone. Moreover, crosslinking improves the 
biologic stability of the novel biomaterial. All these characteristics of the fibrin-
incorporated matrix make this membrane a potentially more ideal barrier for GTR 
procedures to enhance periodontal wound healing.  
 
 
  
 
1 
Introduction 
Chronic periodontitis refers to the inflammation and progressive destruction of the 
supporting tissues of the periodontium resulting in loss of periodontal ligament and alveolar 
bone.
 1
 Restoration of the lost periodontium from periodontal disease is a paramount goal of 
periodontal therapy. Guided tissue regeneration (GTR) aims to regenerate the lost attachment 
apparatus by inducing the formation of new cementum, a new periodontal ligament and new 
alveolar bone through the use of a barrier membrane.
2 
The principle of GTR is based on the 
concept of epithelial exclusion by preventing the down-growth of epithelium to allow 
mesenchymal stem cells from the PDL to repopulate the root surface and promote regeneration.
3
 
The use of a barrier membrane in GTR also plays an important role in space maintenance 
and stabilization of the clot in the initial phases of wound healing.
4
 Different types of barrier 
membranes are available on the market ranging from synthetic to biologic membranes.  The 
benefits of biologic membranes, such as collagen-based membranes, include biocompatibility, 
biodegradability and capability of promoting wound healing. In vivo studies have demonstrated 
that collagen materials can positively influence chemotaxis of periodontal ligament fibroblasts
5 
and gingival fibroblasts
6 
to effect repair of damaged tissues.  Although the biodegradable nature 
of biologic membranes eliminates the need for surgical membrane retrieval, this can also be a 
disadvantage when success of surgical treatment necessitates membrane presence at surgical site 
for an extended period of time.  Synthetic membranes, on the other hand, due to their inert nature 
offer the advantage of slower resorption over biologic membranes.  However, synthetic 
membranes do not actively contribute to wound healing.  Furthermore, complications have also 
been reported such as infection during membrane exposures that can negatively influence clinical 
outcomes of regenerative procedures.
 7
 
  
 
2 
There are various techniques to create synthetic membranes, and one method is through 
the use of electrospinning.  Electrospun scaffolds are created from polymeric solutions through 
application of a high electric field between a positively charge syringe tip and a negatively 
charged collector.
8
 The benefit of using an electrospun scaffold is the ability to adjust and control 
the size of the produced fibers to create structures that closely simulate the architecture of the 
natural biologic extracellular matrix. Importantly, the electrospun nanofiber structure of the 
scaffolds is ideal for cell adhesion due to a greater availability of surface area for cellular 
interactions.
 9
 
The ability to add biologic activity to a synthetic membrane could have profound clinical 
implications in periodontal surgical treatments.  In wound healing, formation of a stable fibrin 
clot is critical. Importantly, the fibrin clot serves as an excellent natural scaffold that provides a 
conductive surface for cell attachment, adhesion and migration during the initial phase of 
healing.
 10    
By incorporating a fibrin matrix into an electrospun scaffold, this novel membrane 
will have the stability of a synthetic membrane to function as an excellent space maintainer, as 
well as, the biological activity of the fibrin to positively influence wound healing.  
Therefore, the objective of this study is to identify optimal conditions to incorporate the 
fibrin matrix into the electrospun scaffold and to characterize the biologic stability and 
mechanical properties of this novel biomaterial compared to fibrin matrices alone. 
 
 
 
  
 
3 
Methods 
Electrospinning 
Polycaprolactone (PCL) was dissolved in hexafluroisopropanol (HFP) at a concentration of 
150mg/ml overnight. Once completely dissolved, polymer solution was subjected to previously 
defined electrospinning conditions (rate: 7 ml/hr, air-gap distance: 12.5 cm, voltage: 22 kV) onto 
a rotating mandrel revolving at 1000 rpm. 
11
 After electrospinning, scaffold was removed from 
mandrel and cut into 3”x1” uniform pieces.  Scaffolds were treated with acid conditioning using 
38% hydrochloric acid and washed with PBS for 5 minutes.  
 
Preparation of fibrin-incorporated electron scaffold 
Firbin matrices and fibrin-incorporated electrospun scaffolds were created at three different 
centrifugation conditions: 400g for 12 minutes, 1450g for 15 minutes and 3000g for 60 minutes.  
Twelve replicates were created for each of the centrifugation conditions. Each sample was 
prepared using 4mL of fresh frozen human plasma at 37
o
C mixed with 100µL of 1M CaCl2 into 
scaffold containing test tubes under sterile conditions.  After centrifugation, the cylindrical-
shaped fibrin clots and fibrin-incorporated electrospun scaffolds were gently removed and 
compressed to make membranes (Figure 1). 
 
Genipin crosslinking of fibrin-incorporated electrospun scaffolds 
Under sterile conditions, half of the compressed membranes created at 400g, 1450g and 3000g 
were placed in six well culture plates and submerged in 4mL of 1% genipin for 48 hours.  After 
48 hours, membranes were washed twice with PBS.  All uncrosslinked (UN-XL) and crosslinked 
  
 
4 
(XL) membranes were stored at 4
o
C in PBS solution until mechanical proprieties of the samples 
were analyzed.  
 
Biodegradation assay with trypsin 
The effect of crosslinking on the fibrin clot and fibrin-incorporated electrospun scaffold was 
assayed by trypsin degradation. Six samples of the fibrin clot alone and six samples of the fibrin-
incorporated electrospun scaffolds were created from each of the centrifugation conditions at 
400g, 1450g and 3000g. Half of the samples were later cross-linked with 1% genipin for 
48hours, as previously described. Following crosslinking, samples were placed in six well 
culture plates, mixed with 500L of 0.01% trypsin and incubated at 37oC for 48 hours (Figure 2). 
All samples were individually weigh prior to degradation assay, and measured again at the 
completion of 48 hours (Figure 3).  
 
Uniaxial tensile testing 
The mechanical properties of the electrospun scaffold alone (S), uncrosslinked fibrin clots (UN-
XL-F, crosslinked fibrin clots (XL-F), uncrosslinked fibrin-incoporated electrospun scaffold 
(UN-XL-S) and crosslinked fibrin-incorporated scaffolds (XL-S) were analyzed by uniaxial 
tensile testing. Preparation for uniaxial testing involved determining the thickness of each 
scaffold and cutting it into “dog bone” specimens measuring 2.75mm wide at their narrowest 
point with a length of 7.5mm (Figure 4).  Each specimen was then mounted onto the MTS 
Bionix 200 testing system (MTS Systems Corp) and stretched at rate of 10.0mm/min (Figure 5).  
Elastic modulus, energy to break and strain at break were calculated by MTS software 
TestWorks 4.0 and recorded.  
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Statistical Analyses 
Multi-way ANOVA models were used to assess the relationship between various measures 
(degradation, modulus, strain at break, energy to break) based on the presence or absence of the 
scaffold, crosslinking, and centrifuge speed. A three-way interaction was fit to allow for 
differences based on the combination. Post-hoc pairwise comparisons were performed to 
determine where there were differences in materials combinations. A conservative Tukey’s HSD 
adjustment was used to account for multiple comparisons. A significance level of 0.05 and SAS 
EG v6.1 was used for all analyses.  
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Result 
ANOVA model results are presented in Table 1 for each of the measures of interest. This table 
shows what factors were associated with differences in stability, modulus, strain at break, and 
energy to break. Specifically, presence of a scaffold is statistically significant for all outcomes, 
but was influenced by other factors (centrifuge rate and/or crosslinking) on trypsin degradation, 
modulus, and strain at break. Crosslinking was significant for all outcomes except modulus (p-
value=0.0969). Centrifuge rates were significantly associated with differences in trypsin 
degradation and modulus. 
 
Baseline scaffold mechanical properties  
Results from the uniaxial tensile strength test of the electrospun scaffold alone reported a mean 
modulus value of 47MPa. The strain at break was 4.1 and the energy to break was 100.7N*mm 
(Table 2).   
Trypsin Degradation 
Results from ANOVA model of the percent of the sample remaining after 48 hour degradation 
with trypsin demonstrated a significant 3-way interaction for the presence of a scaffold, cross-
linking, and the centrifuge rate  (p-vlaue= 0.0064).  The highest percent remaining was seen with 
crosslinked samples with scaffold when spun at 1450g, though this combination was not 
significantly different from that at 400g, or the samples with no scaffold when spun at 400g or 
1450g and crosslinked. The general trend is that increased centrifuge rates decrease the 
degradation, cross-linking greatly increases the percent remaining, and the addition of the 
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scaffold provides marginal, but not significant increased stability. Estimated percent remaining is 
presented in Figure 6. All pairwise comparisons of interest are presented in Table 3.  
 
Modulus 
There was a significant interaction between the presence of the scaffold and the centrifuge rate 
when modeling modulus (p-value=0.0007).  Specifically, there were no significant differences in 
modulus based on centrifuge rate for fibrin matrix alone, but with fibrin+scaffold, as the 
centrifuge rate increased the modulus decreased. There was a statistically significantly higher 
modulus for samples with scaffold when spun at 400g vs 3000g (p-value<0.0001) (Table 4). 
Overall, modulus was greatly increased with the presence of the scaffold (average 52.9 vs 
1.1MPa). The effect of crosslinking was marginal but not statistically significant (0.0969). Figure 
7 presents the estimated modulus for each sample combination. Pairwise comparisons by 
scaffold and centrifuge rate are presented in Table 4.  
 
Strain at Break 
The effect of crosslinking on strain at break was different based on the presence of a scaffold (p-
value<0.0001) (Table 1).  Centrifuge speed was not significantly associated with a change in 
strain at break (p-value=0.2116). The effect of crosslinking was negligible for samples with no 
scaffold (p-value-0.9116), but significant in presence of scaffold. For samples with scaffold, 
crosslinking significantly decreased the strain at break by an average of 1.44mm/mm (p-
value<0.0001). The greatest strain at break was seen in un-crosslinked samples with a scaffold, 
spun at 1450g, but this was not significantly different from samples at either of the other two 
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centrifuge rates (400 or 3000g). Figure 8 presents the estimated mean strain at break and Table 5 
presents the pairwise comparisons for the interaction of scaffold and crosslinking. 
 
Energy to Break 
The only statistically significant predictor of energy to break was the presence or absence of a 
scaffold (p-value<0.0001) (Table 1).  The presence of a scaffold increased the energy to break by 
over 90N*mm (Table 5). After adjusting for scaffold, the effects for the crosslinking and 
centrifuge rate were not significantly different. Estimated mean energy to break is presented in 
Figure 9.  
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Discussion 
In this study, the initial objective was to identify the optimal centrifugation   conditions to 
create a biologically active membrane by incorporating fibrin matrix into an electrospun 
scaffold. It is known, based on the principle of centrifugation, that altering the centrifugation 
force will influence the rate of sedimentation.
12
 Specifically, that increasing the centrifugation 
force leads to greater compaction and formation of a denser construct.  Applying this concept, 
three varying centrifugation speeds (400g, 1450g and 3000g) were selected to evaluate effects on 
the mechanical properties of the novel membrane. 400g was selected as the benchmark since this 
is the centrifugation protocol currently used for the creation of L-PRF through the Intra-Spin 
system (Intra-Lock)
13
.  3000g was selected as the upper limit of the centrifugation speed as this 
was the greatest speed permitted on the centrifuge. Lastly, 1450g was selected as the relative 
halfway mark between 400g and 3000g. It was hypothesized that the membranes created at 
3000g would exhibit enhanced mechanical properties due to greater condensation of the fibrin 
matrix at an increased centrifugation force.  
Based on the results from the uniaxial mechanical test, the mechanical properties of the 
fibrin-incorporated electrospun scaffold exhibited similar characteristics at 400g and 1450g with 
no statistical significant difference in the modulus, energy to break or strain at break. Meanwhile, 
the novel membrane created at 3000g exhibited a statistically significant decrease in the 
modulus, irrespective if the membrane was crosslinked, compared to membranes created at 400g 
or 1450g (Figure 7). However, centrifugation speed at 3000g did not show any statistical 
significant difference in the strain at break or energy to break compared to 400g or 1450g.  
The modulus describes the elastic properties of a material and measures the resistance of 
the material to elastic deformation under load
14
.  In other words, the modulus refers to the 
  
 
10 
stiffness of the material.  Our study reported that an increase in the centrifugation speed altered 
the stiffness of the membrane. In clinical practice, a membrane with a higher modulus would be 
preferred since this would imply that the material can withstand greater stress and minimally 
changes its shape under elastic load.  It is possible that a significant increase in the centrifugation 
force did not allow the fibrin matrix to properly engage with the nanostructure of the electrospun 
scaffold during the polymerization process. Rather, the fibrin matrix was simply layered on top 
of the scaffold and thus membranes created at 3000g lacked the inherent stiffness of the scaffold 
and could explain the observed decrease in modulus.  
 The ability to affect the stability of the novel biomaterial was also examined through the 
effects of crosslinking. Crosslinking is the process of chemically joining two or more molecules 
together with the purpose of stabilizing the protein structure
15
. Fibrin is generally present up to 1 
week in the body before it is remodeled during wound healing
16
.  It was hypothesized that 
crosslinking can increase the stability of the fibrin matrix and increase resistance against 
enzymatic degradation to trypsin. Trypsin is a serine protease found in the human body and 
functions to hydrolyze protein
17
. The trypsin degradation assay is an indirect method to evaluate 
the stability of the fibrin matrix after crosslinking and to assess if the addition of an electrospun 
scaffold would alter the stability of the fibrin clot.  
Our study showed a general trend that crosslinking significantly increased the stability of 
both the fibrin clots and fibrin-incorporated electrospun scaffolds (Figure 6).   This was 
evidenced by a statistically greater percentage of remaining constructs after the 48-hour 
incubation period with trypsin.  Moreover, in the absence of crosslinking, the addition of scaffold 
was beneficial and decreased the degradation of the fibrin matrix. However, in the presence of 
crosslinking, the addition of the scaffold provided marginal but not significant increase in 
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stability.  The one exception was seen in the 3000g group where the addition of scaffold to 
crosslinking significantly decreased the rate of degradation.  It is likely that the increase in 
centrifugation speed altered the fibrin polymerization process and negatively impacted the 
structural architecture of the fibrin matrix, especially in the absence of a scaffold. However, with 
the addition of the scaffold to the fibrin matrix at 3000g, it was able to compensate for changes 
in the structural integrity of the fibrin clot and improve the overall stability.  
The effect of crosslinking was also observed in the mechanical properties of the novel 
biomaterial, specifically decreasing the strain at break. In fact, in the presence of crosslinking 
and scaffold, the strain at break is reduced to the same levels of the fibrin matrix alone 
irrespective of crosslinking. The strain at break of a material refers to the maximum stress a 
material can stand before it breaks as stress is applied to the material
18
. A decrease in the strain at 
break translates into a material that exhibits a decrease in the ability to be stretched. One possible 
explanation is that crosslinking can result in significant dehydration making the material more 
stiff and reduces ability to be stretched. However, when the membrane is uncrosslinked, the 
presence of scaffold significantly increased the strain at break allowing the membrane to be 
stretched.  
In conclusion, our results showed that the combined presence of both the fibrin matrix 
and electrospun led to statistically significant improvements in mechanical properties. 
Meanwhile, crosslinking enhanced the biologic stability of the fibrin matrix as evidenced by a 
greater resistance against enzymatic degradation following the trypsin degradation assay. Lastly, 
centrifugation speeds at 400g and 1450g produced membranes exhibiting similar mechanical 
properties. However, at 3000g the mechanical properties were negatively influenced by an 
increase in the centrifugation speed. Based on the results of this study, our recommendation for a 
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novel membrane that exhibits enhanced biologic stability and superior mechanical properties are 
crosslinked fibrin-incorporated scaffold generated at 400g. In summary, creation of a hybrid 
barrier membrane that contains biologically active fibrin matrix into a synthetic polymeric 
electrospun scaffold has great potential as a novel biomaterial in periodontal surgery.
 13 
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Figure 1: Preparation of fibrin-incorporated electrospun scaffold -A) Cylindrical-shaped fibrin-
incorporated electrospun scaffolds were created at 400g, 1450g, and 3000g, B) gently 
compressed to form membranes  
 
(A)                       
                  400g        1450g            3000g 
(B)  
 
Figure 2: Biodegradation assay with trypsin - biological stability of the fibrin matrices and fibrin-
incorporated scaffolds was evaluated with resistance against enzymatic degradation to trypsin 
(A- uncrosslinked, B- crosslinked samples)  
 
(A)            400g            1450g           3000g 
             
(B)            400g             1450g           3000g 
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Figure 3: Biodegradation assay with trypsin - completion of biodegradation assay following 48-
hour incubation period with trypsin at 37 C degrees (A- uncrosslinked, B- crosslinked samples) 
 
(A)            400g            1450g           3000g 
        
(B)           400g             1450g           3000g 
            
 
 
 
Figure 4: Preparation of specimens for uniaxial tensile testing - Preparation of samples into “dog 
bone” specimens measuring 2.75mm wide at their narrowest point with a length of 7.5mm 
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Figure 5: Uniaxial tensile testing - Illustration of mounted specimen on the MTS Bionix Uniaxial 
Tensile Testing System to characterize the mechanical properties of the fibrin-incorporated 
electrospun scaffold  
                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
18 
Figure 6: Mean Percent Remaining after Trypsin Degradation 
 
 
 
Figure 7: Estimated Mean Modulus (MPa) 
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Figure 8:  Estimated Strain at Break  
 
Figure 9: Estimated Energy to Break (N*mm) 
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Table 1: ANOVA Model Results 
  
Trypsin 
Degradation Modulus 
Strain at 
Break 
Energy to 
Break 
Scaffold (Yes/No) <.0001* <.0001* <.0001* <.0001* 
Centrifuge Rate (400, 1450, 3000) <.0001* 0.0008* 0.2116 0.5871 
Crosslinking (XL or UNXL) <.0001* 0.0969 <.0001* 0.0736 
Scaffold*Centrifuge Rate <.0001* 0.0007* 0.2777 0.5974 
Centrifuge Rate * Crosslinking <.0001* 0.8140 0.9735 0.2512 
Scaffold*Crosslinking 0.2290 0.1307 <.0001* 0.0544 
Scaffold*Centrifuge 
Rate*Crosslinking 0.0064* 0.8352 0.4000 0.2831 
*Statistically significant at 0.05 level 
Table 2: Baseline Scaffold Mechanical Properties 
  Mean             Standard Deviation 
Modulus (MPa) 47.0              1.44 
Strain at Break (mm/mm) 4.1              0.37 
Energy to Break (N*mm) 100.7              6.72 
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Table 3: Pairwise Comparisons of Percent Remaining for Scaffold, Crosslinking, Centrifuge 
Rates 
Comparison 
Estimated Difference  
(% Remaining) Adj P 
No Scaffold at 400g: UNXL vs XL -60% <.0001* 
No Scaffold at 1450g: UNXL vs XL -89% <.0001* 
No Scaffold at 3000g: UNXL vs XL -30% <.0001* 
Scaffold at 400g: UNXL vs XL -83% <.0001* 
Scaffold at 1450g: UNXL vs XL -77% <.0001* 
Scaffold at 3000g: UNXL vs XL -33% <.0001* 
No Scaffold UNXL: 400g vs 1450g 36% <.0001* 
No Scaffold UNXL: 400g vs 3000g 36% <.0001* 
No Scaffold UNXL: 1450g vs 3000g 0% 1 
No Scaffold XL: 400g vs 1450g 6% 0.9887 
No Scaffold XL: 400g vs 3000g 66% <.0001* 
No Scaffold XL: 1450g vs 3000g 59% <.0001* 
Scaffold UNXL: 400g vs 1450g -7% 0.9637 
Scaffold UNXL: 400g vs 3000g -32% <.0001* 
Scaffold UNXL: 1450g vs 300g -25% 0.0001* 
Scaffold XL: 400g vs 1450g -1% 1 
Scaffold XL: 400g vs 3000g 18% 0.0235* 
Scaffold XL: 1450g vs 3000g 19% 0.0096* 
UNXL at 400g: No Scaffold vs Scaffold 20% 0.0044* 
UNXL at 1450g: No Scaffold vs Scaffold -22% 0.001* 
UNXL at 3000g: No Scaffold vs Scaffold -47% <.0001* 
XL at 400g: No Scaffold vs Scaffold -3% 1 
XL at 1450g: No Scaffold vs Scaffold -11% 0.6658 
XL at 3000g: No Scaffold vs Scaffold  -51% <.0001* 
 
Table 4: Comparison of Mean Modulus by Scaffold and Centrifuge Rates 
Comparison Estimated Difference (MPa) Adj P 
400g: No Scaffold vs Scaffold -65.70 <.0001 
1450g: No Scaffold vs Scaffold -52.21 <.0001 
3000g: No Scaffold vs Scaffold -37.60 <.0001 
No Scaffold: 1450g vs 3000g -0.20 1 
No Scaffold: 400g vs 1450g -0.01 1 
No Scaffold: 400g vs 3000g -0.21 1 
Scaffold: 1450g vs 3000g 14.41 0.0403 
Scaffold: 400g vs 1450g 13.47 0.0600 
Scaffold: 400g vs 3000g 27.88 <.0001 
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Table 5: Comparison of Mean Strain at Break by Scaffold and Crosslinking 
Comparison Estimated Difference (mm/mm) Adj P 
UNXL: No Scaffold vs Scaffold -1.09 <.0001* 
No Scaffold: UNXL vs XL 0.09 0.9116 
Scaffold: UNXL vs XL 1.44 <.0001* 
XL: No Scaffold vs Scaffold 0.26 0.2193 
 
Table 6: Estimated Mean Energy to Break for Scaffold (Yes/No) 
Scaffold  
Estimated Mean  
(N*mm) SE P-value* 
No Scaffold  2.0 3.55  
Scaffold 95.5 3.45  
Difference (No Scaffold-Scaffold) -93.5 4.95 <0.0001 
 *P-value for t-test of difference in means 
 
 
